Cargando…

Complete radiological response to first-line regorafenib in a patient with abdominal relapse of BRAF V600E mutated GIST

Up to 13% of KIT and PDGFRA wild-type (WT) gastrointestinal stromal tumours (GIST) harbour a BRAF mutation, mostly involving the exon 15 V600E hot spot. Even if BRAF mutation is recognized as druggable target in other solid tumours, currently advanced BRAF-mutant GIST share the same therapeutical al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nannini, Margherita, Valerio, Di Scioscio, Gruppioni, Elisa, Altimari, Annalisa, Chiusole, Benedetta, Saponara, Maristella, Pantaleo, Maria Abbondanza, Brunello, Antonella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328213/ https://www.ncbi.nlm.nih.gov/pubmed/32647535 http://dx.doi.org/10.1177/1756284820927305

Ejemplares similares

Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib
por: Nannini, Margherita, et al.
Publicado: (2019)

Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST
por: Astolfi, Annalisa, et al.
Publicado: (2020)

Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation
por: Indio, Valentina, et al.
Publicado: (2020)

Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis
por: Rizzo, Alessandro, et al.
Publicado: (2020)

Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor
por: Lolli, Cristian, et al.
Publicado: (2011)

Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours
por: SAPONARA, MARISTELLA, et al.
Publicado: (2014)

Targeted therapy in SDH-deficient GIST
por: Nannini, Margherita, et al.
Publicado: (2021)

Current status of the adjuvant therapy in uterine sarcoma: A literature review
por: Rizzo, Alessandro, et al.
Publicado: (2019)

The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST)
por: Rizzo, Alessandro, et al.
Publicado: (2021)

Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre
por: De Leo, Antonio, et al.
Publicado: (2023)

Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice
por: Nannini, Margherita, et al.
Publicado: (2017)

Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)
por: Nannini, Margherita, et al.
Publicado: (2014)

Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report
por: De Leo, Antonio, et al.
Publicado: (2018)

Gene Expression Landscape of SDH-Deficient Gastrointestinal Stromal Tumors
por: Indio, Valentina, et al.
Publicado: (2021)

Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS‐P WT GIST
por: Urbini, Milena, et al.
Publicado: (2019)

Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling
por: Pantaleo, Maria A., et al.
Publicado: (2021)

Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib
por: Pantaleo, Maria Abbondanza, et al.
Publicado: (2012)

Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST)
por: Astolfi, Annalisa, et al.
Publicado: (2015)

(18)F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature
por: Saponara, Maristella, et al.
Publicado: (2018)

Genetic aberrations and molecular biology of cardiac sarcoma
por: Urbini, Milena, et al.
Publicado: (2020)

Radiotherapy in the management of gist: state of the art and new potential scenarios
por: Gatto, L., et al.
Publicado: (2017)

Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene
por: Indio, Valentina, et al.
Publicado: (2018)

Three cases of bone metastases in patients with gastrointestinal stromal tumors
por: Di Scioscio, Valerio, et al.
Publicado: (2011)

Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST
por: Urbini, Milena, et al.
Publicado: (2020)

Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS)
por: Saponara, Maristella, et al.
Publicado: (2015)

SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update
por: Schipani, Angela, et al.
Publicado: (2023)

miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs
por: Ravegnini, Gloria, et al.
Publicado: (2022)

Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature
por: Gatto, Lidia, et al.
Publicado: (2020)

The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
por: Nannini, Margherita, et al.
Publicado: (2017)

SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor
por: Pantaleo, Maria A., et al.
Publicado: (2022)

Erratum to: The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
por: Nannini, Margherita, et al.
Publicado: (2017)

The emerging role of insulin-like growth factor 1 receptor (IGF1r) in gastrointestinal stromal tumors (GISTs)
por: Pantaleo, Maria A, et al.
Publicado: (2010)

Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib
por: Pallotti, Maria Caterina, et al.
Publicado: (2012)

Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways
por: Pantaleo, Maria A, et al.
Publicado: (2015)

Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2020)

Regorafenib: Adding to the Armamentarium for Refractory Colorectal Cancer and GIST
por: Roman, Danielle, et al.
Publicado: (2013)

Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response
por: Pantaleo, Maria A., et al.
Publicado: (2019)

BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma
por: Repaci, Andrea, et al.
Publicado: (2019)

Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis
por: Ravegnini, Gloria, et al.
Publicado: (2015)

SDHC methylation in gastrointestinal stromal tumors (GIST): a case report
por: Urbini, Milena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2t39vclrfvi862vnrjakhvm0ik